SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-014839
Filing Date
2022-03-24
Accepted
2022-03-24 16:02:33
Documents
49
Period of Report
2022-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea157352-8k_tffpharmace.htm   iXBRL 8-K 28491
2 PRESS RELEASE DATED MARCH 24, 2022 REGARDING THE REGISTRANT'S FINANCIAL RESULTS ea157352ex99-1_tffpharmace.htm EX-99.1 110010
3 THE COMPANY'S INVESTOR PRESENTATION MATERIALS ea157352ex99-2_tffpharmace.htm EX-99.2 48743
4 GRAPHIC ex99-1_001.jpg GRAPHIC 9447
5 GRAPHIC ex99-2_001.jpg GRAPHIC 118627
6 GRAPHIC ex99-2_002.jpg GRAPHIC 190555
7 GRAPHIC ex99-2_003.jpg GRAPHIC 148457
8 GRAPHIC ex99-2_004.jpg GRAPHIC 140425
9 GRAPHIC ex99-2_005.jpg GRAPHIC 115486
10 GRAPHIC ex99-2_006.jpg GRAPHIC 129698
11 GRAPHIC ex99-2_007.jpg GRAPHIC 130663
12 GRAPHIC ex99-2_008.jpg GRAPHIC 119478
13 GRAPHIC ex99-2_009.jpg GRAPHIC 159817
14 GRAPHIC ex99-2_010.jpg GRAPHIC 122503
15 GRAPHIC ex99-2_011.jpg GRAPHIC 136489
16 GRAPHIC ex99-2_012.jpg GRAPHIC 149195
17 GRAPHIC ex99-2_013.jpg GRAPHIC 136047
18 GRAPHIC ex99-2_014.jpg GRAPHIC 108520
19 GRAPHIC ex99-2_015.jpg GRAPHIC 159191
20 GRAPHIC ex99-2_016.jpg GRAPHIC 149080
21 GRAPHIC ex99-2_017.jpg GRAPHIC 124177
22 GRAPHIC ex99-2_018.jpg GRAPHIC 104354
23 GRAPHIC ex99-2_019.jpg GRAPHIC 158396
24 GRAPHIC ex99-2_020.jpg GRAPHIC 120617
25 GRAPHIC ex99-2_021.jpg GRAPHIC 120095
26 GRAPHIC ex99-2_022.jpg GRAPHIC 124731
27 GRAPHIC ex99-2_023.jpg GRAPHIC 118504
28 GRAPHIC ex99-2_024.jpg GRAPHIC 155708
29 GRAPHIC ex99-2_025.jpg GRAPHIC 138927
30 GRAPHIC ex99-2_026.jpg GRAPHIC 243774
31 GRAPHIC ex99-2_027.jpg GRAPHIC 183135
32 GRAPHIC ex99-2_028.jpg GRAPHIC 179380
33 GRAPHIC ex99-2_029.jpg GRAPHIC 225031
34 GRAPHIC ex99-2_030.jpg GRAPHIC 176549
35 GRAPHIC ex99-2_031.jpg GRAPHIC 130713
36 GRAPHIC ex99-2_032.jpg GRAPHIC 135438
37 GRAPHIC ex99-2_033.jpg GRAPHIC 106403
38 GRAPHIC ex99-2_034.jpg GRAPHIC 103469
  Complete submission text file 0001213900-22-014839.txt   7113215

Data Files

Seq Description Document Type Size
39 XBRL SCHEMA FILE tffp-20220324.xsd EX-101.SCH 3036
40 XBRL LABEL FILE tffp-20220324_lab.xml EX-101.LAB 34476
41 XBRL PRESENTATION FILE tffp-20220324_pre.xml EX-101.PRE 22597
43 EXTRACTED XBRL INSTANCE DOCUMENT ea157352-8k_tffpharmace_htm.xml XML 3704
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 22766464
SIC: 2834 Pharmaceutical Preparations